Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression

被引:0
|
作者
Yishan He
Xinguang Qiu
机构
[1] the First Affiliated Hospital of Zhengzhou University,Department of Breast Surgery
[2] the First Affiliated Hospital of Zhengzhou University,Department of Thyroid Surgery
来源
关键词
Glioma; miR-124; lncRNA HOXA11-AS; Cell proliferation; Invasion; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Our aim was to clarify the regulations of lncRNA HOXA11-AS (HOXA11-AS) played on the progression of glioma as well as to investigate the mechanisms by which HOXA11-AS modulated development of glioma. This study confirmed the regulations of miR-124 and HOXA11-AS on the progression of glioma. Here, HOXA11-AS was overexpressed and miR-124 was underexpressed in glioma. Expression of miR-124 was negatively related to that of HOXA11-AS. Silencing of HOXA11-AS suppressed cell proliferation, invasion, and promoted apoptosis in glioma cells in vitro. Moreover, inhibition of HOXA11-AS expression repressed glioma xenograft tumor growth. Expression of miR-124 was repressed by HOXA11-AS functioning as sponge. In addition, miR-124 knockdown partially abolished the inhibitory roles of HOXA11-AS downregulation in glioma cells. Conclusively, this study suggested that silencing of HOXA11-AS restrained proliferation, invasion, induced apoptosis of glioma cells, and repressed xenograft growth via modulating miR-124 expression and thus inhibited glioma progression.
引用
收藏
页码:815 / 822
页数:7
相关论文
共 50 条
  • [1] Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression
    He, Yishan
    Qiu, Xinguang
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2021, 79 (04) : 815 - 822
  • [2] LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma
    Lu, Qinkang
    Zhao, Na
    Zha, Guiping
    Wang, Huiyun
    Tong, Qihu
    Xin, Shuanghua
    DNA AND CELL BIOLOGY, 2017, 36 (10) : 837 - 844
  • [3] lncRNA HOXA11-AS is involved in fracture healing through regulating mir-124-3p
    Wang, X. -N.
    Zhang, L. -H.
    Cui, X. -D.
    Wang, M. -X.
    Zhang, G. -Y.
    Yu, P. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (21) : 4771 - 4776
  • [4] LncRNA HOXA11-AS Aggravates Keloid Progression by the Regulation of HOXA11-AS-miR-205-5p-FOXM1 Pathway
    Su, Xiaoguang
    Ma, Yaohui
    Wang, Qing
    Gao, Yanjun
    JOURNAL OF SURGICAL RESEARCH, 2021, 259 : 284 - 295
  • [5] LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p
    Zhan, Meixiao
    He, Ke
    Xiao, Jing
    Liu, Fei
    Wang, Haihe
    Xia, Zhenglin
    Duan, Xiaopeng
    Huang, Rui
    Li, Yong
    He, Xu
    Yin, Hua
    Xiang, Guoan
    Lu, Ligong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) : 3758 - 3767
  • [6] HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2
    Wen-long Zhang
    Ya-nan Zhao
    Zhang-zhen Shi
    Gui-ying Gu
    Dan Cong
    Chen Wei
    Yuan-song Bai
    Human Cell, 2019, 32 : 504 - 514
  • [7] HOXA11-AS promotes the migration and invasion of hepatocellular carcinoma cells by inhibiting miR-124 expression by binding to EZH2
    Zhang, Wen-long
    Zhao, Ya-nan
    Shi, Zhang-zhen
    Gu, Gui-ying
    Cong, Dan
    Wei, Chen
    Bai, Yuan-song
    HUMAN CELL, 2019, 32 (04) : 504 - 514
  • [8] LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS
    Xu, Jiapeng
    Zhang, Yu
    You, Qing
    Fu, Hongbing
    Zhao, Xiaokai
    Lu, Kai
    Yan, Ronglin
    Yang, Dejun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2623 - 2629
  • [9] MiR-124 inhibits malignant biological behaviors of glioma cells by targeting SDCBP
    Ma, Banyou
    He, Xiwu
    Li, Yadong
    Zhang, Shukun
    Hu, Weixing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 486 - 493
  • [10] Solamargine Inhibits the Development of Hypopharyngeal Squamous Cell Carcinoma by Decreasing LncRNA HOXA11-As Expression
    Meng, Ying
    Jin, Mengli
    Yuan, Dai
    Zhao, Yicheng
    Kong, Xiangri
    Guo, Xuerui
    Wang, Xingye
    Hou, Juan
    Wang, Bingmei
    Song, Wu
    Tang, Yong
    FRONTIERS IN PHARMACOLOGY, 2022, 13